Literature DB >> 34930032

Successful Treatment of Disseminated Disease Due to Highly Resistant Aspergillus calidoustus with a Novel Antifungal Therapy.

Jose F Camargo1, Ra'ed Jabr1, Anthony D Anderson2, Lazaros Lekakis3, Meilin Diaz-Paez3, Laurence M Briski4, Mohammed Raja1, Michele I Morris1, Krishna V Komanduri3, Denise Pereira3.   

Abstract

Invasive aspergillosis is the most common invasive mold infection following a hematopoietic cell transplant. Widespread use of antifungal prophylaxis has led to the increasing incidence of cryptic Aspergillus species. Aspergillus calidoustus is one of those emerging species and is notorious for multidrug resistance to antifungals. Here, we report a case of disseminated A. calidoustus infection in a hematopoietic stem cell transplant recipient who was successfully treated with combination therapy that included a novel antifungal.

Entities:  

Keywords:  APX001; Aspergillus calidoustus; hematopoietic cell transplant

Mesh：

Substances：

Year:  2021        PMID： 34930032      PMCID： PMC8923188          DOI： 10.1128/aac.02206-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


  12 in total

Review 1.  Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Authors:  Juliette Pavie; Claire Lacroix; Dea Garcia Hermoso; Marie Robin; Christèle Ferry; Anne Bergeron; Martine Feuilhade; Françoise Dromer; Eliane Gluckman; Jean-Michel Molina; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient.

Authors:  Maria A Mendoza; Anthony Anderson; Michele I Morris; Lazaros Lekakis; Jacques Simkins; Clara E Prado; Octavio V Martinez; Krishna V Komanduri; Jose F Camargo
Journal:  Mycopathologia       Date:  2020-01-10       Impact factor: 2.574

Review 3.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Authors:  Dimitrios P Kontoyiannis; Kieren A Marr; Benjamin J Park; Barbara D Alexander; Elias J Anaissie; Thomas J Walsh; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa Papanicolaou; Thomas F Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

5.  Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Authors:  William J Steinbach; Kieren A Marr; Elias J Anaissie; Nkechi Azie; Shun-Ping Quan; Herwig-Ulf Meier-Kriesche; Senu Apewokin; David L Horn
Journal:  J Infect       Date:  2012-08-13       Impact factor: 6.072

6.  Clinical and Microbiological Characteristics of Proven Invasive Aspergillosis Due to Rare/Cryptic Species in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Ryosuke Yamamuro; Muneyoshi Kimura; Yuki Asano-Mori; Masahiro Abe; Shigeki Nakamura; Takashi Umeyama; Satoshi Yamagoe; Yoshitsugu Miyazaki; Sho Ogura; Takashi Sakoh; Takashi Mitsuki; Kyosuke Yamaguchi; Mitsuhiro Yuasa; Daisuke Kaji; Kosei Kageyama; Aya Nishida; Yuki Taya; Kazuya Ishiwata; Shinsuke Takagi; Hisashi Yamamoto; Go Yamamoto; Naoyuki Uchida; Atsushi Wake; Shuichi Taniguchi; Hideki Araoka
Journal:  Antimicrob Agents Chemother       Date:  2021-11-15       Impact factor: 5.938

7.  Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.

Authors:  Emmanouil Glampedakis; Sophie Cassaing; Arnaud Fekkar; Eric Dannaoui; Marie-Elisabeth Bougnoux; Stéphane Bretagne; Dionysios Neofytos; Peter W Schreiber; Christophe Hennequin; Florent Morio; Olga Shadrivova; Felix Bongomin; Mario Fernández-Ruiz; Anne Pauline Bellanger; Sevtap Arikan-Akdagli; Veronique Erard; Maria Aigner; Michela Paolucci; Nina Khanna; Eléna Charpentier; Christine Bonnal; Sophie Brun; Frederic Gabriel; Arnaud Riat; Reinhard Zbinden; Patrice Le Pape; Nikolai Klimko; Russel E Lewis; Malcolm Richardson; Ahmet Cagkan İnkaya; Alix T Coste; Pierre-Yves Bochud; Frederic Lamoth
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 9.079

8.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

Review 9.  The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.

Authors:  Martin Hoenigl; Rosanne Sprute; Matthias Egger; Amir Arastehfar; Oliver A Cornely; Robert Krause; Cornelia Lass-Flörl; Juergen Prattes; Andrej Spec; George R Thompson; Nathan Wiederhold; Jeffrey D Jenks
Journal:  Drugs       Date:  2021-10-09       Impact factor: 9.546

10.  Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus.

Authors:  Teclegiorgis Gebremariam; Sondus Alkhazraji; Abdullah Alqarihi; Nathan P Wiederhold; Karen Joy Shaw; Thomas F Patterson; Scott G Filler; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191
View more
  1 in total

1.  Case Commentary: Long-Term Fosmanogepix Use in a Transplant Recipient with Disseminated Aspergillosis Caused by Azole-Resistant Aspergillus calidoustus.

Authors:  Ahnika Kline; Michail S Lionakis
Journal:  Antimicrob Agents Chemother       Date:  2022-01-24       Impact factor: 5.938
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.